Name,Empirical formula,CAS,SMILES,Canonical SMILES,"Mw, g*mol-1","CC50/IC50/EC50, mM","Statistics (95% CI, SEM, SD, RMSE, SE etc.)","Incubation time, h",Cell line,Method,Reference (author+year+journal),doi,Notes
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium (1-hydroxyethane-1,1-diyl)bis(hydrogen phosphonate)",C16H32N4O7P2,2871700-87-5,C1CN2CCC[NH+]=C2C1.C1CN2CCC[NH+]=C2C1.CC(O)(P(=O)([O-])O)P(=O)(O)[O-],C1C[NH+]=C2CCCN2C1.C1C[NH+]=C2CCCN2C1.CC(O)(P(=O)([O-])O)P(=O)([O-])O,454.401,18.6,,24,Fibro,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,Human gingival finroblasts. CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium (1-hydroxyethane-1,1-diyl)bis(hydrogen phosphonate)",C16H32N4O7P2,2871700-87-5,C1CN2CCC[NH+]=C2C1.C1CN2CCC[NH+]=C2C1.CC(O)(P(=O)([O-])O)P(=O)(O)[O-],C1C[NH+]=C2CCCN2C1.C1C[NH+]=C2CCCN2C1.CC(O)(P(=O)([O-])O)P(=O)([O-])O,454.401,0.002,,24,MG63,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,[Cl-].C1CN2CCC[NH+]=C2C1,C1C[NH+]=C2CCCN2C1.[Cl-],160.648,3.8e-05,,24,Fibro,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,Human gingival finroblasts. CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,[Cl-].C1CN2CCC[NH+]=C2C1,C1C[NH+]=C2CCCN2C1.[Cl-],160.648,0.00028,,24,T-47D,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,[Cl-].C1CN2CCC[NH+]=C2C1,C1C[NH+]=C2CCCN2C1.[Cl-],160.648,9.8e-05,,24,MG63,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (1-hydroxy-1-phosphonoethyl)phosphonate",C9H20N2O7P2,2871700-86-4,C1CN2CCC[NH+]=C2C1.CC(O)(P(=O)(O)O)P(=O)(O)[O-],C1C[NH+]=C2CCCN2C1.CC(O)(P(=O)([O-])O)P(=O)(O)O,330.214,11.4,,24,Fibro,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,Human gingival finroblasts. CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (1-hydroxy-1-phosphonoethyl)phosphonate",C9H20N2O7P2,2871700-86-4,C1CN2CCC[NH+]=C2C1.CC(O)(P(=O)(O)O)P(=O)(O)[O-],C1C[NH+]=C2CCCN2C1.CC(O)(P(=O)([O-])O)P(=O)(O)O,330.214,0.00093,,24,T-47D,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (1-hydroxy-1-phosphonoethyl)phosphonate",C9H20N2O7P2,2871700-86-4,C1CN2CCC[NH+]=C2C1.CC(O)(P(=O)(O)O)P(=O)(O)[O-],C1C[NH+]=C2CCCN2C1.CC(O)(P(=O)([O-])O)P(=O)(O)O,330.214,0.002,,24,MG63,MTT,"Teixeira, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121262,CAS for neutral compound
